Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Selinexor 60 mg - Phase 2 | KPTI Pipeline | CatalystAlert

Selinexor 60 mg

Phase 2

Karyopharm Therapeutics Inc. (KPTI)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Apr 2026~

KPTIPhase 2Phase 2

Selinexor 60 mg Phase 2 Results Expected

Selinexor 60 mg • Myelofibrosis

Drug Information

Target Indication

Myelofibrosis

Clinical Trial

Last updated: 12/4/2025

Developer

KPTI

Karyopharm Therapeutics Inc.

Biotechnology•North America•NASDAQ